Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -16.95% vs -0.90% in Mar 2025
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is 18.18% vs 11.39% in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is -6.23% vs -15.00% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is 11.99% vs 19.28% in Mar 2025
Compare Balance Sheet Results of Goldline Pharmac
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
8.71
12.47
-3.76
-30.15%
Share Warrants & Outstandings
Total Reserve
5.54
54.24
-48.70
-89.79%
Shareholder's Funds
14.25
66.71
-52.46
-78.64%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
3.21
0.00
3.21
0.00%
Secured Loans
0.66
0.00
0.66
0.00%
Unsecured Loans
2.55
0.00
2.55
0.00%
Deferred Tax Assets / Liabilities
-0.08
0.40
-0.48
-120.00%
Other Long Term Liabilities
1.04
0.00
1.04
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
2.43
0.40
2.03
507.50%
Current Liabilities
Trade Payables
1.85
0.00
1.85
0.00%
Other Current Liabilities
2.56
0.23
2.33
1,013.04%
Short Term Borrowings
7.70
0.00
7.70
0.00%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
12.11
0.23
11.88
5,165.22%
Total Liabilities
28.79
67.34
-38.55
-57.25%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
3.76
16.74
-12.98
-77.54%
Less: Accumulated Depreciation
1.06
14.51
-13.45
-92.69%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
2.71
2.23
0.48
21.52%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.03
43.90
-43.87
-99.93%
Long Term Loans & Advances
0.02
0.00
0.02
0.00%
Other Non Current Assets
0.00
0.07
-0.07
-100.00%
Total Non-Current Assets
2.75
46.20
-43.45
-94.05%
Current Assets Loans & Advances
Current Investments
0.00
12.31
-12.31
-100.00%
Inventories
6.21
0.02
6.19
30,950.00%
Sundry Debtors
16.13
2.95
13.18
446.78%
Cash and Bank
0.59
0.01
0.58
5,800.00%
Other Current Assets
1.13
1.52
-0.39
-25.66%
Short Term Loans and Advances
1.98
4.33
-2.35
-54.27%
Total Current Assets
26.05
21.14
4.91
23.23%
Net Current Assets (Including Current Investments)
13.93
20.91
-6.98
-33.38%
Total Current Assets Excluding Current Investments
26.05
8.83
17.22
195.02%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
28.79
67.34
-38.55
-57.25%
Contingent Liabilities
3.37
0.00
3.37
0.00%
Total Debt
7.41
0.00
7.41
0.00%
Book Value per share (adjusted)
18.03
53.50
-35.47
-66.30%
Annual - Borrowings
Borrowings 9.16 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -16.95% vs -0.90% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 1.04 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 18.18% vs 11.39% in Mar 2025
Annual - Fixed Assets
Fixed Assets 2.71 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -6.23% vs -15.00% in Mar 2025
Annual - Investments
Investments 0.03 Cr
in Mar 2026Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 26.05 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 11.99% vs 19.28% in Mar 2025
Footer loading
